Vector Laboratories develops, manufactures and markets labeling and detection reagents for immunohistochemistry, immunofluorescence, DNA/RNA and glycobiology. The company serves customers in disease and therapeutics research with tools that help them precisely visualize and study tissues and cells. A pioneer in a number of innovative technologies, Vector Laboratories has been providing a continuous stream of reliable tools for more than 40 years. With headquarters in Burlingame, California and a subsidiary in Peterborough, UK, the company maintains a network of more than 40 distributors across the globe. A privately held company, Vector Laboratories was acquired by Maravai LifeSciences in 2016.
ImmPRESS™ Polymer Detection Reagents
Vector® M.O.M. Mouse on Mouse Immunodetection Kits
VECTASHIELD® Antifade Mounting Media
VectaCell™ Live Cell Imaging Reagents and Stains
Secondary fluorescent antibody conjugates
Live Cell Imaging
Eric brings over 20 years of experience in investment banking, corporate development and strategy, and operations management focusing on medical devices, diagnostics and life sciences. Prior to founding Maravai LifeSciences, Eric led corporate development and corporate strategy at Gen-Probe leading up to its acquisition by Hologic. Eric began his career as an investment banker executing mergers and acquisitions for Merrill Lynch, Piper Jaffray and Morgan Stanley. Throughout his banking career, Eric centered his attention on medical device companies, with a particular focus on the life sciences tools and diagnostics segments.
David Weber, VP and Chief Commercial Officer
David comes to Maravai LifeSciences with over 35 years of experience in life sciences industry commercial leadership and general management. David is responsible for all marketing, sales, product development, commercial strategy, service, and support for all Maravai LifeSciences portfolio companies. Prior to joining Maravai LifeSciences, David served as Executive Vice President and Chief Commercial Officer for Affymetrix leading up to its acquisition by Thermo Fisher Scientific. Earlier in his career, David held a variety of commercial leadership roles in life science companies including Amersham Biosciences (GE Healthcare), Eksigent Technologies, Cyntellect, Stratagene, and The Linus Group.
Harjit Kullar, VP, Marketing
Harjit comes to Maravai LifeSciences with over 15 years of experience in sales and marketing in the life sciences and diagnostics industries, most recently holding the position of Vice President of Marketing at Transgenomic. Earlier in his career, Harjit held a variety of commercial leadership roles in life science companies including Bio-Rad Laboratories, Thermo Fisher Scientific, Life Technologies, LifeSpan BioSciences and Abcam. Harjit received a BSc in Biochemistry & Pharmacology from University of Southampton, a Ph.D. in Cancer Biology from University of Birmingham and an MBA from University of Cambridge.